Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × IFL protocol × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 13 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Ras-mutated Metastatic Colorectal Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1

Interventions

Cyclophosphamide 21 Rituximab 18 fludarabine 15 obinutuzumab 10 pirtobrutinib 9 fludarabine phosphate 9 venetoclax 8 ibrutinib 7 Prednisone 7 Lenalidomide 7 Biopsy 7 tocilizumab 6 glofitamab 6 Specimen Handling 6 Immunotherapy, Adoptive 6 polatuzumab vedotin 5 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 X-Rays 4 Tacrolimus 4 Phantoms, Imaging 4 Doxorubicin 4 pembrolizumab 3 palbociclib 3 olaparib 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Vincristine 3 Vemurafenib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡